相似文献
1
Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing.
Nat Biotechnol. 2023 Oct;41(10):1410-1415. doi: 10.1038/s41587-023-01679-x. Epub 2023 Mar 30.
2
Synthesis of ionizable lipopolymers using split-Ugi reaction for pulmonary delivery of various size RNAs and gene editing.
Nat Commun. 2025 Apr 29;16(1):4021. doi: 10.1038/s41467-025-59136-z.
3
Cell-Selective Messenger RNA Delivery and CRISPR/Cas9 Genome Editing by Modulating the Interface of Phenylboronic Acid-Derived Lipid Nanoparticles and Cellular Surface Sialic Acid.
ACS Appl Mater Interfaces. 2019 Dec 18;11(50):46585-46590. doi: 10.1021/acsami.9b17749. Epub 2019 Dec 9.
4
Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
Adv Mater. 2019 Aug;31(33):e1902575. doi: 10.1002/adma.201902575. Epub 2019 Jun 19.
5
High content analysis platform for optimization of lipid mediated CRISPR-Cas9 delivery strategies in human cells.
Acta Biomater. 2016 Apr 1;34:143-158. doi: 10.1016/j.actbio.2015.12.036. Epub 2015 Dec 30.
6
Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
Acc Chem Res. 2021 Nov 2;54(21):4001-4011. doi: 10.1021/acs.accounts.1c00500. Epub 2021 Oct 20.
7
Development of ionizable lipid nanoparticles and a lyophilized formulation for potent CRISPR-Cas9 delivery and genome editing.
Int J Pharm. 2024 Mar 5;652:123845. doi: 10.1016/j.ijpharm.2024.123845. Epub 2024 Jan 22.
8
Protocol for Delivery of CRISPR/dCas9 Systems for Epigenetic Editing into Solid Tumors Using Lipid Nanoparticles Encapsulating RNA.
Methods Mol Biol. 2024;2842:267-287. doi: 10.1007/978-1-0716-4051-7_14.
9
Integrating Combinatorial Lipid Nanoparticle and Chemically Modified Protein for Intracellular Delivery and Genome Editing.
Acc Chem Res. 2019 Mar 19;52(3):665-675. doi: 10.1021/acs.accounts.8b00493. Epub 2018 Dec 26.
10
Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges.
Expert Opin Drug Deliv. 2018 Sep;15(9):905-913. doi: 10.1080/17425247.2018.1517746. Epub 2018 Sep 12.
引用本文的文献
1
Muscle-targeting LNP vaccines enable potent immune responses against varicella zoster virus.
Drug Deliv Transl Res. 2025 Sep 1. doi: 10.1007/s13346-025-01961-2.
2
Freeze-Drying of mRNA-LNPs Vaccines: A Review.
Vaccines (Basel). 2025 Aug 12;13(8):853. doi: 10.3390/vaccines13080853.
3
Designing lipid nanoparticles using a transformer-based neural network.
Nat Nanotechnol. 2025 Aug 15. doi: 10.1038/s41565-025-01975-4.
4
In vivo genome editing of human haematopoietic stem cells for treatment of blood disorders using mRNA delivery.
Nat Biomed Eng. 2025 Aug 12. doi: 10.1038/s41551-025-01480-y.
5
Limiting endosomal damage sensing reduces inflammation triggered by lipid nanoparticle endosomal escape.
Nat Nanotechnol. 2025 Aug 11. doi: 10.1038/s41565-025-01974-5.
6
mRNA vaccines for gastrointestinal cancers: a paradigm shift in treatment.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 6. doi: 10.1007/s00210-025-04462-8.
7
Systematic screening of excipients to stabilize aerosolized lipid nanoparticles for enhanced mRNA delivery.
RSC Pharm. 2025 Jul 18. doi: 10.1039/d5pm00061k.
8
Machine learning techniques for lipid nanoparticle formulation.
Nano Converg. 2025 Jul 15;12(1):35. doi: 10.1186/s40580-025-00502-4.
9
Boosting RNA nanotherapeutics with V-ATPase activating non-inflammatory lipid nanoparticles to treat chronic lung injury.
Nat Commun. 2025 Jul 14;16(1):6477. doi: 10.1038/s41467-025-61688-z.
10
Advancements in CRISPR/Cas systems for disease treatment.
Acta Pharm Sin B. 2025 Jun;15(6):2818-2844. doi: 10.1016/j.apsb.2025.05.007. Epub 2025 May 17.
本文引用的文献
1
Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases.
Cells. 2022 Mar 12;11(6):984. doi: 10.3390/cells11060984.
2
Deep Parallel Characterization of AAV Tropism and AAV-Mediated Transcriptional Changes Single-Cell RNA Sequencing.
Front Immunol. 2021 Oct 21;12:730825. doi: 10.3389/fimmu.2021.730825. eCollection 2021.
3
AAV5 delivery of CRISPR-Cas9 supports effective genome editing in mouse lung airway.
Mol Ther. 2022 Jan 5;30(1):238-243. doi: 10.1016/j.ymthe.2021.10.023. Epub 2021 Oct 23.
4
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs.
Nat Biomed Eng. 2021 Sep;5(9):1059-1068. doi: 10.1038/s41551-021-00786-x. Epub 2021 Oct 6.
5
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of .
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2020401118.
6
Host genetics and infectious disease: new tools, insights and translational opportunities.
Nat Rev Genet. 2021 Mar;22(3):137-153. doi: 10.1038/s41576-020-00297-6. Epub 2020 Dec 4.
7
Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing.
Sci Adv. 2020 Aug 21;6(34). doi: 10.1126/sciadv.abc2315. Print 2020 Aug.
8
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future.
Front Oncol. 2020 Aug 7;10:1387. doi: 10.3389/fonc.2020.01387. eCollection 2020.
9
Delivery of genome-editing biomacromolecules for treatment of lung genetic disorders.
Adv Drug Deliv Rev. 2021 Jan;168:196-216. doi: 10.1016/j.addr.2020.05.002. Epub 2020 May 13.
10
Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver.
Nat Commun. 2020 May 15;11(1):2424. doi: 10.1038/s41467-020-16248-y.
Zotero 插件